UF Diabetes Researchers Test Therapy To Prevent Immune Attack Against Insulin-Producing Cells (UF Health)
A UF study led by Edward A. Phelps, as a senior author, outlines a new strategy to potentially slow the progression of Type 1 diabetes using a drug that acts directly on insulin-producing cells in the pancreas.
UF Health Study Maps Hidden Immune Signals in Type 1 Diabetes (UF Health)
UF researchers have created a highly detailed map of gene activity in the pancreas, offering new insights into the biological signals driving Type 1 diabetes despite the absence of a cure.
Markers at Birth May Help Predict Type 1 Diabetes (UF News)
In collaboration with scientists at Linköping University in Sweden, UF researchers have discovered that early signs of type 1 diabetes can be detected in umbilical cord blood—a resource typically discarded at birth.
Researchers Find Vital Clue in the Progression of Type 1 Diabetes (UF Health)
UF researchers have added an important piece to the puzzle in understanding the progression of type 1 diabetes.
UF researchers Contribute to Study on Type 1 Diabetes Progression (UF BME)
A study published in Cell Reports, co-led by UF researchers Edward Phelps and Clayton Mathews, reveals that beta cell dysfunction occurs independently of immune cell infiltration in the pancreas during the onset of type 1 diabetes (T1D).
Gene Therapy Specialist Kriya Raises $313M (Bio Space)
UF startup Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal neuralgia and type 1 diabetes.
UF Health-Led Guidelines Call for Widespread Type 1 Diabetes Screening in Children
UF researcher led an international team of Type 1 diabetes experts who developed new treatment guidelines emphasizing wider screening for the disease among children and adolescents in the general population before symptoms arise.
UF Health Researchers Propose an Update to Type 1 Diabetes Staging System
UF researchers have called for an update to the Type 1 diabetes staging system, urging the development of a more precise risk assessment method to reflect rapid advancements in science and medicine.
Diabetes Detectives
University of Florida aims to improve the lives of millions with diabetes through its clinical and research programs and is globally recognized for its efforts.
First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial
Rise Therapeutics, a clinical-stage biotechnology company developing novel oral immunotherapeutic medicines, announced it has enrolled its first patient in its R-5280 placebo-controlled, blinded, Phase 1b type 1 diabetes clinical trial.